APTOF
Price
$2.20
Change
+$0.08 (+3.77%)
Updated
Apr 25 closing price
Capitalization
5.33M
HUMA
Price
$1.46
Change
+$0.02 (+1.39%)
Updated
Apr 28, 04:59 PM (EDT)
Capitalization
223.37M
11 days until earnings call
Ad is loading...

APTOF vs HUMA

Header iconAPTOF vs HUMA Comparison
Open Charts APTOF vs HUMABanner chart's image
Aptose Biosciences
Price$2.20
Change+$0.08 (+3.77%)
Volume$1.41K
Capitalization5.33M
Humacyte
Price$1.46
Change+$0.02 (+1.39%)
Volume$22.98K
Capitalization223.37M
APTOF vs HUMA Comparison Chart
Loading...
APTOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HUMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APTOF vs. HUMA commentary
Apr 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APTOF is a Hold and HUMA is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 29, 2025
Stock price -- (APTOF: $2.20 vs. HUMA: $1.44)
Brand notoriety: APTOF and HUMA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APTOF: 0% vs. HUMA: 49%
Market capitalization -- APTOF: $5.77M vs. HUMA: $226.47M
APTOF [@Biotechnology] is valued at $5.77M. HUMA’s [@Biotechnology] market capitalization is $226.47M. The market cap for tickers in the [@Biotechnology] industry ranges from $272.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APTOF’s FA Score shows that 0 FA rating(s) are green whileHUMA’s FA Score has 0 green FA rating(s).

  • APTOF’s FA Score: 0 green, 5 red.
  • HUMA’s FA Score: 0 green, 5 red.
According to our system of comparison, APTOF is a better buy in the long-term than HUMA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APTOF’s TA Score shows that 5 TA indicator(s) are bullish while HUMA’s TA Score has 4 bullish TA indicator(s).

  • APTOF’s TA Score: 5 bullish, 5 bearish.
  • HUMA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both APTOF and HUMA are a good buy in the short-term.

Price Growth

APTOF (@Biotechnology) experienced а +11.68% price change this week, while HUMA (@Biotechnology) price change was -14.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.19%. For the same industry, the average monthly price growth was +1.10%, and the average quarterly price growth was -9.09%.

Reported Earning Dates

APTOF is expected to report earnings on Mar 28, 2025.

HUMA is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (+11.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HUMA($223M) has a higher market cap than APTOF($5.33M). APTOF YTD gains are higher at: 876.476 vs. HUMA (-71.485). APTOF has higher annual earnings (EBITDA): -24.82M vs. HUMA (-137.16M). HUMA has more cash in the bank: 20.6M vs. APTOF (3.32M). APTOF has less debt than HUMA: APTOF (10.7M) vs HUMA (17.3M). APTOF (0) and HUMA (0) have equivalent revenues.
APTOFHUMAAPTOF / HUMA
Capitalization5.33M223M2%
EBITDA-24.82M-137.16M18%
Gain YTD876.476-71.485-1,226%
P/E RatioN/AN/A-
Revenue00-
Total Cash3.32M20.6M16%
Total Debt10.7M17.3M62%
FUNDAMENTALS RATINGS
APTOF: Fundamental Ratings
APTOF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APTOFHUMA
RSI
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 4 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
82%
Momentum
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
84%
MACD
ODDS (%)
Bearish Trend 6 days ago
90%
Bullish Trend 4 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
74%
Bearish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 7 days ago
79%
Bullish Trend 5 days ago
79%
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 7 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
88%
Bearish Trend 4 days ago
81%
View a ticker or compare two or three
Ad is loading...
APTOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HUMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RIG2.330.04
+1.75%
Transocean Ltd
ECOR7.570.02
+0.26%
electroCore
ONTF4.690.01
+0.21%
ON24
NGG72.04-0.22
-0.30%
National Grid PLC
ANGI12.32-0.22
-1.75%
Angi Inc

APTOF and

Correlation & Price change

A.I.dvisor tells us that APTOF and BDTX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APTOF and BDTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APTOF
1D Price
Change %
APTOF100%
+3.77%
BDTX - APTOF
30%
Poorly correlated
-1.24%
LOGC - APTOF
28%
Poorly correlated
+2.68%
MDGL - APTOF
28%
Poorly correlated
+2.14%
SLNO - APTOF
28%
Poorly correlated
-1.31%
HUMA - APTOF
27%
Poorly correlated
-2.70%
More

HUMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, HUMA has been loosely correlated with RXRX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if HUMA jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HUMA
1D Price
Change %
HUMA100%
-2.70%
RXRX - HUMA
41%
Loosely correlated
-0.35%
AURA - HUMA
39%
Loosely correlated
-2.54%
KYMR - HUMA
38%
Loosely correlated
-0.89%
TRDA - HUMA
37%
Loosely correlated
-1.34%
CGON - HUMA
36%
Loosely correlated
+3.95%
More